Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |